Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Items 901–1,000 of 1,000
Synthetic biology for improving cell fate decisions and tissue engineering outcomes
Vogel, A. M., Persson, K. M., Seamons, T. R., & Deans, T. L. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20190091 · Cited by 23
Soukup, R., Ribitsch, I., Mohr, T. T., Gültekin, S., Grillari, J., & Jenner, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310857 · Cited by 27
Hu, J., Zhu, Q., Li, P., Wang, W., Yi, F., & Li, N. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373984 · Cited by 23
Aire Controls Mesenchymal Stem Cell-mediated Suppression in Chronic Colitis
Parekkadan, B., Fletcher, A. L., Li, M., Tjota, M. Y., Bellemare‐Pelletier, A., Milwid, J. M., Lee, J., Yarmush, M. L., & Turley, S. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.192 · Cited by 23
Richardson, J. D., Psaltis, P. J., Frost, L., Paton, S., Carbone, A., Bertaso, A., Nelson, A. J., Wong, D. T. L., Worthley, M. I., Gronthos, S., et al. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.07.016 · Cited by 24
“For example, MSCs used for early therapy could be modified to enhance their effects on cardiomyocyte survival (40), cardiac and vascular progenitor cell recruitment and attenuation of inflammatory cell infiltration.”
BackgroundSingla, D. K., Singla, R. D., Lamm, S. M., & Glass, C. E. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00917.2010 · Cited by 23
Flynn, A. W., Chen, X., O’Connell, E., & O’Brien, T. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt127 · Cited by 23
“Modification of cells to enhance the expression of the pro-survival gene Akt1 was required before improvements in survival capacity were observed [9].”
BackgroundInfluentialFidelis-De-Oliveira, P., Werneck‐de‐Castro, J. P., Pinho‐Ribeiro, V., Shalom, B. C. M., Nascimento-Silva, J. H., Costa-e-Sousa, R. H., Cruz, I. S., Rangel, R., Goldenberg, R. C. D. S., & Campos-De-Carvalho, A. C. (2012) · Cell Transplantation · doi:10.3727/096368911x623916 · Cited by 25
Ke, T., Wu, Y., Li, L., Liu, Y., Yao, X., Zhang, J., Kong, D., & Li, C. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.021 · Cited by 23
“…secretion of bioactive factors such as vascular endothelial growth factor (VEGF), monocyte chemotactic protein (MCP)-3, basic fi-broblast growth factor (bFGF), and platelet-derived growth factor (PDGF) (Gnecchi et al. , 2005; Uemura et al. , 2006; Huang et al. , 2011; Figeac et al. , 2014).”
Ee, M. T., & Thébaud, B. (2018) · Current Pediatric Reviews · doi:10.2174/1573396314666180911100503 · Cited by 23
Tissue engineered heart repair from preclinical models to first-in-patient studies
Zimmermann, W. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.02.001 · Cited by 25
Mesenchymal stem cell secretions improve donor heart function following ex vivo cold storage
Wang, M., Yan, L., Li, Q., Yang, Y., Turrentine, M. W., March, K. L., & Wang, I. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.08.095 · Cited by 23
Herrmann, J. L., Abarbanell, A. M., Weil, B. R., Wang, Y., Poynter, J. A., Manukyan, M. C., & Meldrum, D. R. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00084.2010 · Cited by 25
“We and others have reported the paracrine effects of stem cells on recipient tissues and cells (7, 10, 39).”
BackgroundThe future of cell therapy for acute myocardial infarction
Caplice, N. M. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0432 · Cited by 23
Liu, X., Shen, W., Yang, Y., & Liu, G. (2011) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2010.09.040 · Cited by 22
“Recent studies have demonstrated that MSCs can be of therapeutic benefit in the tissue structural repair and prevention of fibrotic lesions, such as lung [31], heart [32], and liver [33-36], without a clear understanding of the therapeutic mechanism by which stem cells act.”
BackgroundBone Marrow-Derived Mesenchymal Stem Cells Modified with Akt1 Ameliorates Acute Liver GVHD
Zhou, L., Liu, S., Wang, Z., Yao, J., Cao, W., Chen, S., Xie, W., Shuqing, F., Xu, Y., Cheng, T., et al. (2019) · Biological Procedures Online · doi:10.1186/s12575-019-0112-2 · Cited by 22
DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis
Zhang, S. J., Zhang, S. J., Meng, H. F., Xu, H. Q., Guo, Z. X., Yan, J. F., Gao, J. L., Niu, L. N., Wang, S. L., & Jiao, K. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03720-5 · Cited by 23
Exosomes: A New Hope for Angiogenesis-Mediated Bone Regeneration
Lange, M., Babczyk, P., & Tobiasch, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105204 · Cited by 22
“In numerous studies, the angiogenic activity of MSC-derived exosomes has been investigated with regard to their impact on different cell types, especially endothelial cells.”
BackgroundEmerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics
Kumar, R., Mishra, N., Tran, T., Kumar, M., Vijayaraghavalu, S., & Gurusamy, N. (2024) · Cells · doi:10.3390/cells13100855 · Cited by 25
“Gnecchi et al. [85] showed that MSCs overexpressing Akt1 enhance myocardial protection post infarction through paracrine mechanisms, reducing apoptosis and improving cardiac function, proposing their secreted factors as potential therapeutic agents for ischemic damage.”
BackgroundBiçer, M. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03055-4 · Cited by 22
“Currently, the predominant therapeutic approach employed to expedite wound healing involves the application of biological agents, such investigations and clinical trials [8 , 9 ].”
BackgroundMolecular physiology of cardiac regeneration
Bolli, P., & Chaudhry, H. W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05814.x · Cited by 22
Bassi, G., Guilloton, F., Menard, C., Trapani, M. D., Deschaseaux, F., Sensebé, L., Schrezenmeier, H., Giordano, R., Bourin, P., Dominici, M., et al. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2014.0269 · Cited by 22
Bakondi, B., Girman, S., Lu, B., & Wang, S. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0181 · Cited by 24
Madonna, R., Angelucci, S., Giuseppe, F. D., Doria, V., Giricz, Z., Görbe, A., Ferdinandy, P., & Caterina, R. D. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.019 · Cited by 25
Strategies for skeletal muscle tissue engineering: seed vs. soil
Sicari, B. M., Londoño, R., & Badylak, S. F. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01714a · Cited by 22
Fu, Y., Azene, N., Ehtiati, T., Flammang, A. J., Gilson, W. D., Gabrielson, K. L., Weiss, C. R., Bulte, J. W. M., Solaiyappan, M., Johnston, P. V., et al. (2014) · Radiology · doi:10.1148/radiol.14131424 · Cited by 22
“There is growing evidence that direct regeneration of cardiomyocytes and vasculature from stem cells transplanted to the heart are limited, and that, instead, the beneficial effects of such cells are mediated through paracrine mechanisms by the secretion of cytoprotective factors and cytokines that induce resident ste…”
BackgroundEngineering Immunomodulatory Biomaterials to Drive Skin Wounds toward Regenerative HealingPreprint
Butenko, S., Miwa, H., Liu, Y., Plikus, M. V., Scumpia, P. O., & Liu, W. F. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041242 · Cited by 25
Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection
Zhang, Y., Chiu, S., Liang, X., Chai, Y.-H., Qin, Y., Wang, J., Li, X., Qiu, B., Tergaonkar, V., Tse, H., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.012 · Cited by 21
Cardiomyocyte Death and Genome-Edited Stem Cell Therapy for Ischemic Heart Disease
Cho, H., & Cho, J. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10096-5 · Cited by 22
“For instance, the VEGF gene contributed to angiogenesis, and the Akt gene contributed to the pro-survival capacity of each cells [23, 24].”
BackgroundPerinatal derivatives: How to best validate their immunomodulatory functions
Papait, A., Silini, A. R., Gazouli, M., Malvicini, R., Muraca, M., O’Driscoll, L., Pacienza, N., Toh, W. S., Yannarelli, G., Ponsaerts, P., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.981061 · Cited by 22
“Indeed, in myocardial infarction models, administration of their conditioned media or encapsulated MSCs induced comparable therapeutic effects to those achieved with systemically applied MSCs (Gnecchi et al., 2005; Gnecchi et al., 2006; Timmers et al., 2007).”
ResultFuzeta, M. D. A., Gonçalves, P. P., Fernandes‐Platzgummer, A., Cabral, J. M. S., Bernardes, N., & da Silva, C. L. (2022) · Bioengineering · doi:10.3390/bioengineering9110675 · Cited by 21
Mesenchymal Stem Cell–Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope?
Zhu, L., Wang, Q., Guo, M., Fang, H., Li, T., Zhu, Y., Jiang, H., Xiao, P., & Hu, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s439974 · Cited by 21
“55 They intramyocardially injected the culture supernatants from MSCs with high Akt gene expression, as well as MSCs alone, into an animal model of acute infarction.”
BackgroundThe Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting
Raynaud, C. M., & Rafii, A. (2013) · Stem Cells International · doi:10.1155/2013/892340 · Cited by 22
“[126] M.”
BackgroundOptimizing adult mesenchymal stem cells for heart repair
Behfar, A., & Terzic, A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.11.003 · Cited by 21
Wuschko, S., Gugerell, A., Chabicovsky, M., Hofbauer, H., Laggner, M., Erb, M., Ostler, T., Peterbauer, A., Suessner, S., Demyanets, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42057-5 · Cited by 21
Kot, M., Musiał-Wysocka, A., Lasota, M., Ulman, A., & Majka, M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2019_2895 · Cited by 25
Heart Failure and Adipose Mesenchymal Stem Cells
Matsushita, K. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.003 · Cited by 22
Potential Therapeutic Effects of Exosomes in Regenerative Endodontics
Yu, S., Chen, H., & Gao, B. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104946 · Cited by 21
Cellular Therapy in Chagas‘ Disease: Potential Applications in Patients with Chronic Cardiomyopathy
Soares, M. B. P., Garcia, S., de Carvalho, A. C. C., & dos Santos, R. R. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.3.257 · Cited by 21
“A growing body of evidence indicates that most effects of stem cell therapy in cardiac diseases are in fact due to paracrine effects [38,39], through secretion of cytokines that may act on resident mature cells and/or in tissue-specific stem cells.”
BackgroundMesenchymal Stem Cell Therapy for Heart Disease
Gnecchi, M., & Cervio, E. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-200-1_13 · Cited by 23
Self-citationNeuroregulation during Bone Formation and Regeneration: Mechanisms and Strategies
Zhao, X., Yao, M., Wang, Y., Feng, C., Yang, Y., Tian, L., Bao, C., Li, X., Zhu, X., & Zhang, X. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c16786 · Cited by 23
Hong, X., Luo, A. C., Doulamis, I. P., Oh, N. A., Im, G., Lin, C., del Nido, P. J., Lin, R., & Melero‐Martin, J. M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301581 · Cited by 22
Light therapy and stem cells: a therapeutic intervention of the future?
Oron, U. (2011) · Interventional Cardiology · doi:10.2217/ica.11.74 · Cited by 20
Chen, J., Guo, R., Zhou, Q., & Wang, T. (2014) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2013.12.004 · Cited by 20
“Although the underlying mechanisms are a matter of debate, engraftment of BMSCs into ischemic myocardial tissue and their consecutive paracrine effects are intended to substantially attenuate morphological and functional postinfarction remodeling [9].”
BackgroundPark, J. H., Jang, H. R., Kim, D. H., Kwon, G. Y., Lee, J. E., Huh, W., Choi, S. J., Oh, W., Oh, H. Y., & Kim, Y.-G. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00097.2016 · Cited by 20
“MSCs show low immunogenicity and have immunomodulatory activity, suppressing inflammatory cytokine production and augmenting the levels of anti-inflammatory cytokines and chemokines (3, 7, 32, 33).”
BackgroundIravani, K., Sobhanmanesh, A., Ashraf, M. J., Hashemi, S. B., Mehrabani, D., & Zare, S. (2017) · PubMed Central · Cited by 25
Huang, S., Li, Y., Wang, X., Ma, X., & Zhang, X. (2017) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2017.1388556 · Cited by 20
Chu, X., Xu, B., Gao, H., Li, B., Liu, Y., Reiter, J. L., & Wang, Y. (2019) · Stem Cells and Development · doi:10.1089/scd.2018.0213 · Cited by 20
Raval, A. N., Johnston, P. V., Duckers, H. J., Cook, T. D., Traverse, J. H., Altman, P. A., Dhingra, R., Hematti, P., Borrello, I., Anderson, R. D., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.10.043 · Cited by 20
Kwon, J., Schumacher, S. M., Gao, E., Chuprun, J. K., Ibetti, J., Roy, R., Khan, M., Kishore, R., & Koch, W. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00571.2020 · Cited by 20
Cell Tracking and the Development of Cell-Based Therapies
Rodriguez-Porcel, M. G., Kronenberg, M. W., Henry, T. D., Traverse, J. H., Pepine, C. J., Ellis, S. G., Willerson, J. T., Moyé, L. A., & Simari, R. D. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.12.018 · Cited by 20
Klinger, R. Y., & Bursac, N. (2008) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2007.913849 · Cited by 20
“... and 4) Which donor cell type(s) will offer the most benefit with the least risk? Furthermore, the mechanisms underlying the functional improvements observed in clinical trials have yet to be defined and may be the result of transdifferentiation of the injected cells, direct functional integration of the donor cell…”
BackgroundStem Cell Therapy for Incontinence: Where Are We Now? What is the Realistic Potential?
Dissaranan, C., Cruz, M. A., Couri, B. M., Goldman, H. B., & Damaser, M. S. (2011) · Current Urology Reports · doi:10.1007/s11934-011-0210-4 · Cited by 20
“Although low cell retention and survival rate after transplantation are major problems with cell-based therapy, there is functional improvement despite the low number of engrafted cells in multiple injury models such as spinal cord injury, stroke, and myocardial infarction [22, 24, 38, 39].”
BackgroundDrosha regulates hMSCs cell cycle progression through a miRNA independent mechanism
Oskowitz, A., Penfornis, P., Tucker, A., Prockop, D. J., & Pochampally, R. R. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.07.005 · Cited by 20
“…have demonstrated significant therapeutic capability in a variety of disease processes (Kocher et al., 2001, Kinnaird et al., 2004, Kurokawa et al., 2005, Al-Khaldi et al., 2003, Lee et al., 2006, Gnecchi et al., 2005, Chopp and Li, 2002, Wu et al., 2007, Spees et al., 2008, Ohtaki et al., 2008).”
BackgroundChen, W., Hsu, W.-T., Yen, M.-H., Changou, C. A., Han, C., Chen, Y., Cheng, J., Chang, T., Lee, O. K., & Ho, J. H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.026 · Cited by 20
Jang, M. J., You, D., Park, J. Y., Kim, K., Aum, J., Lee, C., Song, G., Shin, H. C., Suh, N., Kim, Y. M., et al. (2018) · International Journal of Stem Cells · doi:10.15283/ijsc18073 · Cited by 21
Дергилев, К. В., Shevchenko, E. K., Цоколаева, З. И., Beloglazova, I. B., Zubkova, E., Boldyreva, M. A., Menshikov, M. Y., Ratner, E. I., Penkov, D., & Parfyonova, Y. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249603 · Cited by 20
“Thus, an apoptotic caspase 8 knockdown in MSCs [19] or introduction of Akt1 protein kinase [20] reduced transplanted cell death and elimination.”
BackgroundShigematsu, K., Takeda, T., Komori, N., Tahara, K., & Yamagishi, H. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110572 · Cited by 24
Treatment of pulmonary arterial hypertension with circulating angiogenic cells
Mirsky, R. S., Jahn, S., Koskenvuo, J. W., Sievers, R. E., Yim, S., Ritner, C., Bernstein, H. S., Angeli, F. S., Boyle, A., Marco, T. D., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00215.2010 · Cited by 21
Cai, B., Wang, G., Chen, N., Liu, Y., Yin, K., Ning, C.-P., Xing-da, L., Yang, F., Wang, N., Wang, Y., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12287 · Cited by 19
“Accordingly, BMSCs become an attractive stem cell candidate for cardiovascular repair [4, 5].”
BackgroundEffect of disruption of Akt-1 of lin-c-kit+ stem cells on myocardial performance in infarcted heart
Tseng, A., Stabila, J. P., McGonnigal, B., Yano, N., Yang, M., Tseng, Y. T., Davol, P., Lum, L. G., Padbury, J. F., & Zhao, T. C. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq110 · Cited by 19
“Our results are in line with the observations that Akt-1 has been regarded as an important mechanism whereby stem cells generate these protective effects.(22,31) Figure 3 (A) The effects of infusion of the armed lin2c-kit+ on heart/body ratio (left) and lung/body ratio (right) in infarcted myocardium.”
ResultMin, Y., Han, S.-H., Ryu, H. A., & Kim, S. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy086 · Cited by 19
Luo, W., Gong, Y., Qiu, F., Yuan, Y., Jia, W., Liu, Z., & Gao, L. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00855.2020 · Cited by 19
Mas‐Bargues, C., Alique, M., Barrús, M. T., Borrás, C., & Rodrigues‐Díez, R. (2021) · Antioxidants · doi:10.3390/antiox11010078 · Cited by 22
Therapeutic properties of stem cell-derived exosomes in ischemic heart disease
Raissi-Dehkordi, N., Raissi-Dehkordi, N., & Farjoo, M. H. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174839 · Cited by 19
Points to Consider in Designing Mesenchymal Stem Cell-Based Clinical Trials
Brooke, G. P., Rossetti, T. R., Ilić, N., Murray, P. A., Hancock, S., Pelekanos, R., & Atkinson, K. (2008) · Transfusion Medicine and Hemotherapy · doi:10.1159/000143158 · Cited by 20
The Role of Cytoprotective Cytokines in Cardiac Ischemia/Reperfusion Injury
Anderson, C. D., Heydarkhan‐Hagvall, S., Schenke‐Layland, K., Yang, J. Q., Jordan, M. C., Kim, J. K., Brown, D. A., Zuk, P. A., Laks, H., Roos, K. P., et al. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.08.005 · Cited by 19
Hogendoorn, S., Duijnisveld, B. J., van Duinen, S. G., Stoel, B. C., van Dijk, J. G., Fibbe, W. E., & Nelissen, R. G. H. H. (2014) · Bone and Joint Research · doi:10.1302/2046-3758.32.2000229 · Cited by 19
“3 months 392 (165) 391 (44) 274 (71) 347 (98) Mean difference +138 +218 +103 0.”
Brain mesenchymal stem cells: physiology and pathological implications
Pombero, A., García‐López, R., & Martínez, S. (2016) · Development Growth & Differentiation · doi:10.1111/dgd.12296 · Cited by 21
“Transplanted MSCs exert beneficial effects by their differentiation capability (Zhao et al. 2002; Dai et al. 2005; Fazel et al. 2005) and by secreting trophic factors (Kinnaird et al. 2004; Gnecchi et al. 2005; *Author to whom all correspondence should be addressed.”
BackgroundLee, C., Jang, M. J., Kim, B. H., Park, J. Y., You, D., Jeong, I. G., Hong, J. H., & Kim, C. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2585-0 · Cited by 20
Gopinath, S., Vanamala, S. K., Gondi, C. S., & Rao, J. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.021 · Cited by 19
Transplantation of Undifferentiated, Bone Marrow‐Derived Stem Cells
Pauwelyn, K. A., & Verfaillie, C. M. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)74007-8 · Cited by 19
Moraddahande, F. M., Meybodi, S. M. E., Matin, M., Soleimani, N., Ghasemzadeh, N., & Firoozabadi, A. D. (2025) · European journal of medical research · doi:10.1186/s40001-025-03018-z · Cited by 20
Choi, D., Cho, K., Kim, J.-W., Lee, H., Kim, Y., Park, J.-W., & Woo, S. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5054 · Cited by 19
EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities
Heydari, Z., Peshkova, M., Gonen, Z. B., Coretchi, I., Eken, A., Yay, A. H., Dogan, M. E., Gokce, N., Akalin, H., Kosheleva, N., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02276-2 · Cited by 18
Wang, W., Xu, Z., Liu, M., Cai, M., & Liu, X. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1278124 · Cited by 18
“As elucidated in the research conducted by Gnecchi et al., MSCs exert their effect primarily through paracrine mechanisms (Gnecchi et al., 2005; Phan et al., 2018).”
MethodDiabetes-associated macrovascular complications: cell-based therapy a new tool?
Gili, M., Orsello, A., Gallo, S., & Brizzi, M. F. (2013) · Endocrine · doi:10.1007/s12020-013-9936-8 · Cited by 19
Laggner, M., Copic, D., Nemec, L., Vorstandlechner, V., Gugerell, A., Грубер, Ф., Peterbauer, A., Ankersmit, H. J., & Mildner, M. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102774 · Cited by 19
“Pursuing studies administering conditioned medium from mesenchymal SCs to injured cardiac tissues revealed that secreted factors, rather than SCs themselves, exert beneficial paracrine effects and account for most of the initial findings [27-29].”
ResultKorkmaz‐Icöz, S., Zhou, P., Guo, Y., Loganathan, S., Brlecic, P., Radovits, T., Sayour, A. A., Ruppert, M., Veres, G., Karck, M., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02166-3 · Cited by 18
Li, Y., Ricardo, S. D., & Samuel, C. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116035 · Cited by 20
“The genetic engineering of BM-MSCs has been employed to enhance several properties of these cells that have directly been linked to their therapeutic outcome(s), including the (1) homing (e.g., when over-expressing insulin-like growth factor IGF-1 [99] or C-C chemokine receptor type 1 CCR1 [100]); (2) survival (via hy…”
BackgroundPeng, C., Pei, H., Wei, F. F., Tian, X., Deng, J., Yan, C., Li, Y., Sun, M., Zhang, J., Liu, D., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.059 · Cited by 19
de Morais, S. D. B. V., Silva, L. E. V., Lataro, R. M., Silva, C. A. A., de Oliveira, L. F. L., de Carvalho, E. E. V., Simões, M. V., Meirelles, L. D. S., Fazan, R., & Salgado, H. C. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0573 · Cited by 18
Challenges in the Translation of Cardiovascular Cell Therapy
Gupta, R., & Losordo, D. W. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.068304 · Cited by 18
Targeting protein kinase B/Akt signaling with vanadium compounds for cardioprotection
Bhuiyan, M. S., Shioda, N., & Fukunaga, K. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1217 · Cited by 18
“Moreover, activation of Akt in mesenchymal stem cells may enhance cardiac function in heart failure models to a greater extent than that observed in nontransduced stem cells [42,43] .”
BackgroundHwang, H., & Kloner, R. A. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182058717 · Cited by 20
Mesenchymal Stromal Cells to Halt the Progression of Type 1 Diabetes?
Carlsson, P., Korsgren, O., & Blanc, K. L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0616-3 · Cited by 19
Cell Therapy for Acute Myocardial Infarction
Gulati, R., & Simari, R. D. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.03.003 · Cited by 18
Role of Tumor Necrosis Factor Receptor 1 in Sex Differences of Stem Cell Mediated Cardioprotection
Zeller, C. N., Wang, Y., Markel, T. A., Weil, B. R., Abarbanell, A. M., Herrmann, J. L., Kelly, M. L., Coffey, A. C., & Meldrum, D. R. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.12.033 · Cited by 18
Lupu, M., Khalil, M., Iordache, F., Andrei, E., Pfannkuche, K., Spitkovsky, D., Baumgartner, S., Rubach, M., Abdelrazik, H., Buzilă, C. A., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01197.x · Cited by 18
“In the randomized clinical trials of intracoronary bone marrowderived mononuclear cell therapy employed for the treatment of acute myocardial infarction [44, 45], the modest and transient clinical benefits, most likely exerted by paracrine mechanisms [46], might be caused by the failure of the injected cells to integr…”
BackgroundLi, J., Zhang, L., Zhou, L., Yu, Z., Feng, Q., Liu, B., Zi, S.-X., Li, L., Li, Y., Wang, S., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-102 · Cited by 17
“Although cord blood stem cells can differentiate into diverse cell lineages [28], the injected cells stimulate the intrinsic stem cells to help them proliferate and differentiate [29].”
BackgroundSelf-citationZhou, T., Rong, M., Wang, Z., Chu, H., Chen, C., Zhang, J., & Tian, Z. (2021) · Cell Proliferation · doi:10.1111/cpr.13129 · Cited by 17
Chowdhury, M. A., Zhang, J. J., Rizk, R., & Chen, W. C. W. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1344885 · Cited by 20
Gao, L., Bledsoe, G., Yin, H. H., Shen, B., Chao, L., & Chao, J. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1585 · Cited by 17
Bone marrow as a target and accomplice of vascular complications in diabetes
Santopaolo, M., Sambataro, M. P., Spinetti, G., & Madeddu, P. R. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3240 · Cited by 19
“marker CD34, can exert proangiogenic activities via paracrine mechanisms.(12,13)”
BackgroundXue, E., Minniti, A., Alexander, T., Papa, N. D., Greco, R., & on behalf of The Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2022) · Cells · doi:10.3390/cells11213346 · Cited by 18
“Similar results were shown in other settings, including myocardial infarction [54] and cerebral ischemia [55]; in the latter, MSCs injection determined prolonged benefits despite the majority of MSCs failing to engraft and only a minority differentiating into astrocytes.”
ResultWang, B., Ma, X., Zhao, L., Zhou, X., Yitong, M., Sun, H., Yang, Y., & Chen, B. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0383-0 · Cited by 18
Chen, T. ‐., Wang, J., Shi, H., Gui, C., Luo, R., Xie, X., Xiang, M., Zhang, X., & Cao, J. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510801918761 · Cited by 17
“The transgenic expression of AKT [16] or fibroblast growth factor-2 [17] in MSCs has been shown to improve the survival of the donor cell and improve cardiac function.”
BackgroundA Crucial Role of Activin A-Mediated Growth Hormone Suppression in Mouse and Human Heart Failure
Fukushima, N., Matsuura, K., Akazawa, H., Honda, A., Nagai, T., Takahashi, T., Seki, A., Murasaki, K., Shimizu, T., Okano, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027901 · Cited by 18
Chang, Y. H., Lin, L., Lou, C.-W., Chou, C.-K., & Ch’ang, H.-J. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.10.005 · Cited by 17
“The mechanisms of BM in ameliorating wound injury or ischemic damage were demonstrated to be related to angiogenic paracrine action in various organs [7–10].”
BackgroundMaddox, J. R., Ludlow, K. D., Li, F., & Niyibizi, C. (2012) · Cells Tissues Organs · doi:10.1159/000331332 · Cited by 17
“The therapeutic effects of MSCs are presently attributed in part to trophic factors generated by the cells that modulate the mi- croenvironment for tissue repair [Gnecchi et al., 2005; Caplan, 2007].”
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.